Cargando…
Potential of E3 Ubiquitin Ligases in Cancer Immunity: Opportunities and Challenges
Cancer immunotherapies, including immune checkpoint inhibitors and immune pathway–targeted therapies, are promising clinical strategies for treating cancer. However, drug resistance and adverse reactions remain the main challenges for immunotherapy management. The future direction of immunotherapy i...
Autores principales: | Ye, Peng, Chi, Xiaoxia, Cha, Jong-Ho, Luo, Shahang, Yang, Guanghui, Yan, Xiuwen, Yang, Wen-Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699390/ https://www.ncbi.nlm.nih.gov/pubmed/34943817 http://dx.doi.org/10.3390/cells10123309 |
Ejemplares similares
-
T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications
por: Chi, Xiaoxia, et al.
Publicado: (2023) -
Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells
por: Luo, Shahang, et al.
Publicado: (2022) -
Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities
por: Landré, Vivien, et al.
Publicado: (2014) -
E3 ubiquitin ligases: styles, structures and functions
por: Yang, Quan, et al.
Publicado: (2021) -
Immune regulation by protein ubiquitination: roles of the E3 ligases VHL and Itch
por: Aki, Daisuke, et al.
Publicado: (2018)